Searchable abstracts of presentations at key conferences in endocrinology

ea0035p967 | Thyroid (non-cancer) | ECE2014

Usefulness of color-flow doppler ultrasonography in the differential diagnosis of thyrotoxicosis in outpatients

Merchante Agustin Angel , Fabra Amparo , Garcia Lourdes , Tolosa Mercedes , Ferrer Juan Carlos , Sanchez Carlos

Objective: To evaluate the role of thyroid blod flow assessment by color-flow Doppler ultrasonography in the differential diagnosis of thyrotoxicosis in an outpatient endocrinology clinic.Material and methods: Consecutive patients with thyrotoxicosis presenting to our center between January–December 2013 were included in the study. Clinical date were collected and measurements of TSH, serum free thyroxine and TSH receptor antibodies were performed. ...

ea0077p78 | Neuroendocrinology and Pituitary | SFEBES2021

The role of FGF signaling pathway in the pituitary stem cell compartment

Abascal Sherwell Sanchez Carlos M. , Lodge Emily , Willis Thea L. , Hajihosseini Mohammad K. , Andoniadou Cynthia L.

The FGF signalling pathway regulates cell proliferation, differentiation, migration and cell specification in mutliple developing and adult tissues. It has also been implicated in tumor development and progression with a significant role in the cancer pathobiology of several malignant tumors including melanoma, breast, pancreas, head and neck and non-small lung cell cancer. FGF signalling plays a major role in the postnatal hypothalamic-pituitary (HP) axis, with dysregulation ...

ea0037ep1044 | Thyroid (non-cancer) | ECE2015

Usefulness of the assessment of thyroid blood flow as a predictor of relapse of Graves' disease

Merchante Agustin Angel , Garcia-Blasco Lourdes , Perez Susana , Fabra Amparo , Cubells Pilar , Sanchez Carlos

Objective: We investigated the clinical usefulness of thyroid blood flow measurement by colour-flow Doppler ultrasonography in predicting relapse of Graves’ disease (GD).Patients and methods: In 30 euthyroid GD patients, (eight males and 23 females), aged 17–68 years (mean 43.8±12.8), after at least 1 year of treatment with anti-thyroid drug (ATD) and just before its withdrawal, we evaluate with colour-flow Doppler ultrasonography the colo...

ea0041ep69 | Adrenal cortex (to include Cushing's) | ECE2016

Hyperparathyroidism healing in patients treated for hyperaldosteronism: three cases

Blasco Lourdes Garcia , Garcia Juan Carlos Ferrer , Torrens Mercedes Tolosa , Revert Pablo Sanz , Alacid Cristian Marco , Juan Carlos Sanchez

Introduction: Hyperaldosteronism usually presents with hypertension and hypokalemia; however, there is recent evidence of a relationship with the parathyroid hormone. There are different theories to try to explain this relationship. Hyperaldosteronism treatment is medical or surgical depending upon etiology. We present three cases in which treatment solely for hyperaldosteronism also cured hyperparathyroidism.Materials and methods: We report three patien...

ea0086oc4.2 | Adrenal and Cardiovascular | SFEBES2022

Generation of novel tools for the study and development of targeted therapeutic approaches for pheochromocytoma and paraganglioma

Kemkem Yasmine , Santambrogio Alice , Montibus Bertille , Abascal Sherwell Sanchez Carlos , Willis Thea L. , Lodge Emily J. , Yianni Val , Oakey Rebecca J. , Andoniadou Cynthia L.

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumours, which arise from neural crest (NC)-derived structures: the adrenal medulla and the paraganglia. Around one third of PPGLs are associated with inherited cancer susceptibility genes, the highest rate among all tumour types. Currently, the only diagnostic criterion for malignant disease is the presence of metastasis and no molecular or histological features have been identified that help predict risk. A...

ea0056p606 | Obesity | ECE2018

Differences in percentage of weight loss and secondary effects after one and two months of treatment with liraglutide versus naltrexone/bupropion

Voltas Arribas Beatriz , Juan Carlos Sanchez , Garcia Juan Carlos Ferrer , Fullana Ana Artero , Revert Pablo Sanz , Alacid Cristian Marco , Merseguer Mario Lopez

Introduction: Obesity is one of the most prevalent health problems in our society. The marketing of Liraglutide and the Naltrexone/Bupropion combination has been given the green light.Objectives: To analyze the differences in a series of 19 patients assigned to treatment with Liraglutide or Naltrexone/Bupropion.Material and methods: A descriptive analysis was carried out using Stata. 19 patients were included, 9 were treated with L...

ea0090ep437 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Real-world effectiveness analysis of oral versus subcutaneous semaglutide in patients with type 2 diabetes mellitus

Ferrer Garcia Juan Carlos , Albalat-Galera Raquel , Moya Victor Atienza , Hernandez Jessica Sanchez , Palomar Luis Arribas , Casamayor Ignacio Ramos , Fullana Ana Artero , Blanco Cintia Gonzalez , Portilla Ana Jimenez , Juan Carlos Sanchez

Background and Objective: Semaglutide, a glucagon-like peptide 1 (GLP1a) receptor agonist, reduces the risk of major adverse cardiovascular events in patients with type 2 diabetes mellitus (DM2). An oral version of semaglutide is now available, and patients may prefer it to the subcutaneous form. Our objective was to compare the effectiveness and safety of both formulations in real life.Methods: Retrospective real-world efficacy analysis including aGLP1-...